- Home
- GH vs BDC Comparison
GH vs BDC Comparison
Compare GH & BDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- BDC
- Stock Information
- Founded
- GH 2011
- BDC 1902
- Country
- GH United States
- BDC United States
- Employees
- GH N/A
- BDC N/A
- Industry
- GH Medical Specialities
- BDC Telecommunications Equipment
- Sector
- GH Health Care
- BDC Telecommunications
- Exchange
- GH Nasdaq
- BDC Nasdaq
- Market Cap
- GH 4.7B
- BDC 4.9B
- IPO Year
- GH 2018
- BDC 1993
- Fundamental
- Price
- GH $45.13
- BDC $120.71
- Analyst Decision
- GH Strong Buy
- BDC Strong Buy
- Analyst Count
- GH 14
- BDC 4
- Target Price
- GH $39.93
- BDC $122.75
- AVG Volume (30 Days)
- GH 1.9M
- BDC 246.8K
- Earning Date
- GH 02-20-2025
- BDC 02-06-2025
- Dividend Yield
- GH N/A
- BDC 0.16%
- EPS Growth
- GH N/A
- BDC N/A
- EPS
- GH N/A
- BDC 4.29
- Revenue
- GH $692,256,000.00
- BDC $2,346,180,000.00
- Revenue This Year
- GH $32.21
- BDC N/A
- Revenue Next Year
- GH $16.90
- BDC $11.93
- P/E Ratio
- GH N/A
- BDC $28.11
- Revenue Growth
- GH 29.20
- BDC N/A
- 52 Week Low
- GH $15.81
- BDC $72.91
- 52 Week High
- GH $45.66
- BDC $131.82
- Technical
- Relative Strength Index (RSI)
- GH 79.68
- BDC 58.87
- Support Level
- GH $36.45
- BDC $116.23
- Resistance Level
- GH $39.29
- BDC $118.54
- Average True Range (ATR)
- GH 2.35
- BDC 2.93
- MACD
- GH 0.75
- BDC 0.82
- Stochastic Oscillator
- GH 96.63
- BDC 93.08
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About BDC Belden Inc
Belden Inc provides signal transmission products to distributors, end-users, installers, and original equipment manufacturers. The firm operates in two segments - Enterprise Solutions and Industrial Solutions. The Enterprise Solutions segment is a provider in network infrastructure solutions, as well as cabling and connectivity solutions for commercial audio/video and security applications. The Industrial Solutions segment is a provider of high-performance networking components and machine connectivity products. It operates in Americas, EMEA and APAC, out of which maximum revenue from Americas.